NASDAQ:IRIX
IRIDEX Corporation Stock News
$2.85
+0.0296 (+1.05%)
At Close: May 02, 2024
IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript
07:30pm, Tuesday, 26'th Mar 2024
IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
07:06pm, Tuesday, 26'th Mar 2024
Iridex (IRIX) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.07 per share a year ago.
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
04:05pm, Wednesday, 20'th Mar 2024
MOUNTAIN VIEW, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and p
3 Laser Systems Stocks to Watch in a Challenging Industry
10:20am, Wednesday, 21'st Feb 2024
The Zacks Laser Systems and Components industry participants like MicroVision (MVIS), Cutera (CUTR) and IRIDEX Corporation (IRIX) gain from solid demand for emerging applications like autonomous drivi
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
09:00am, Monday, 13'th Nov 2023
The Company also announced plans to present at Stifel Healthcare Conference The Company also announced plans to present at Stifel Healthcare Conference
Iridex to Report Third Quarter Financial Results on November 14, 2023
04:22pm, Thursday, 26'th Oct 2023
MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
IRIDEX Corporation (IRIX) Q2 2023 Earnings Call Transcript
08:33pm, Thursday, 10'th Aug 2023
IRIDEX Corporation (NASDAQ:IRIX ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Philip Taylor - Gilmartin Group David Bruce - President, CEO & Director Fuad Ahmad -
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
07:46pm, Thursday, 10'th Aug 2023
Iridex (IRIX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.14 per share a year ago.
2 Laser Systems Stocks to Buy in a Prospering Industry
02:01pm, Tuesday, 20'th Jun 2023
The Zacks Laser Systems and Components industry participants like IPG Photonics (IPGP) and IRIDEX (IRIX) gain from solid demand for emerging applications like autonomous driving, IoT, 5G and healthcar
Iridex (IRIX) Reports Q1 Loss, Tops Revenue Estimates
07:47pm, Thursday, 11'th May 2023
Iridex (IRIX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.15 per share a year ago.
Iridex to Report First Quarter Financial Results on May 11, 2023
04:05pm, Thursday, 27'th Apr 2023
MOUNTAIN VIEW, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
IRIDEX Corporation (IRIX) Q4 2022 Earnings Call Transcript
10:12pm, Thursday, 09'th Mar 2023
IRIDEX Corporation (NASDAQ:IRIX ) Q4 2022 Earnings Conference Call March 9, 2023 5:00 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group David Bruce - President and CEO Fua
Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates
07:02pm, Thursday, 09'th Mar 2023
Iridex (IRIX) delivered earnings and revenue surprises of 36.36% and 0.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Iridex to Present at the 35th Annual Roth Conference
04:05pm, Tuesday, 07'th Mar 2023
MOUNTAIN VIEW, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
IRIDEX Corporation (IRIX) Q3 2022 Earnings Call Transcript
10:11pm, Thursday, 10'th Nov 2022
IRIDEX Corporation (NASDAQ:IRIX ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants David Bruce - Chief Executive Officer Fuad Ahmad - Interim Chief Financial Officer C